SMTL ID : 5v4m.3 (3 other biounits)

Structure of HLA-DR15 with bound alpha3(135-145) peptide

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

hetero-1-1-mer

Ligands

1 x NAG- FUC- FUC: alpha-L-fucopyranose-(1-3)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-FUC-FUC.1: 2 residues within 4Å: Chain A: R.76, N.78 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.76, A:N.78

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.2: 5 residues within 4Å: Chain A: V.116, N.118, E.166, H.167, W.168 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ooi, J.D. et al., Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells. Nature (2017)

Release Date

2017-05-03

Peptides

HLA-DRA1: A
alpha3(135-145)-HLA-DRB1*15:01: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
G

B
I

HLA-DRA1

alpha3(135-145)-HLA-DRB1*15:01

Related Entries With Identical Sequence